Effectiveness-Implementation Evaluation of Acute Kidney Injury Decision Support
Part of paid clinical trials in Baltimore, Maryland.
- Sponsor
- Johns Hopkins University
- Study ID
- NCT06840210
- Status
- Recruiting
Conditions
- Acute Kidney Injury
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
Study Purpose: This study is testing an artificial intelligence (AI)-powered clinical decision support (CDS) system designed to help emergency department (ED) doctors detect and manage acute kidney injury (AKI) earlier. The goal is to see whether the tool improves patient care, clinician decision-making, and hospital outcomes when used in real-world ED settings. Study Design: The AI tool will be gradually introduced at three hospital EDs: Johns Hopkins Hospital (JHH) Bayview Medical Center (BMC) Howard County General Hospital (HCGH) Before the tool is activated, it will run in the background to collect baseline data without influencing care. Once implemented, doctors will receive training, and researchers will track how often the tool is used and whether it improves AKI care. What the Study Measures: Process Outcomes: Does the tool help doctors identify AKI sooner, avoid harmful medications, and improve decision-making about hospitalization? Clinical Outcomes: Does the tool reduce the number and severity of AKI cases and improve kidney-related health outcomes? Implementation Outcomes: Do ED doctors find the tool useful? Does it fit into the ED doctor's workflow without slowing the ED doctor's down? Expected Impact: If successful, the AI tool could be expanded to other hospitals and used to improve early detection and treatment of AKI, reducing kidney complications and improving patient care nationwide.
Key Dates
- Start date
- Mar 10, 2026
- Status verified
- Apr 2026
- Primary completion
- Dec 1, 2028
- Completion
- Dec 1, 2030
Study Design
- Enrollment
- 200,000 participants (estimated)
Arms
- Arm: All adult ED patients with creatinine concentration measured during the participant's ED stay
Primary Outcome Measure
Number of Patients who receive Guideline-Concordant Kidney Care [ Time Frame: From time of decision support provision until departure from the ED, approximately 6 hours ]
Central Contacts
- Eili Y Klein, PhD732-266-7732
- Michael Ehmann, MD
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Johns Hopkins Hospital | Baltimore | Maryland | 21287 |
Find similar trials in Baltimore, MD
Related Studies
- Acute Normovolemic Hemodilution on Urine Neutrophil Gelatinase-associated Lipocalin LevelsRecruiting · University of Maryland, Baltimore · Baltimore, Maryland
- Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney InjuryRecruiting · SeaStar Medical · Birmingham, Alabama
- A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI TrialRecruiting · University of Pittsburgh · Birmingham, Alabama
- CTSN Embolic Protection TrialRecruiting · Icahn School of Medicine at Mount Sinai · North Little Rock, Arkansas